Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory pharmacokinetic and pharmacodynamic study of cephalosporins and fluoroquinolones in ICU patients
NL-OMON21190Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in bacterial disease, sponsored by Erasmus MC. Primary endpoint: Achievement of PK/PD targets. Started Jan 2016; status: recruiting.
02
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON21190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21190.